Abstract:Background: Rectal cancer (RC) is a malignant tumor that seriously threatens human health. Long non-coding RNAs (lncRNAs) play a vital role in tumor regulation. Nevertheless, their exact expression features and functions remain obscure, and therefore was the aim of the current study. Methods: We utilized the Affymetrix human GeneChip to screen differentially expressed profiles of lncRNAs and mRNAs from the cancer tissues and matched paracancer tissues of 6 RC patients. Gene Ontology (GO) and pathway enrichment analyses identified crucial functions and pathways of the aberrantly expressed mRNAs. We used quantitative real-time polymerase chain reaction to verify the significant expression differences of 11 candidate lncRNAs between the cancer and paracancer tissues. LncRNA-mRNA coexpression networks were built by calculating the Pearson correlation value to identify significant correlation pairs. Online bioinformatics tools GEPIA2, ONCOMINE, and PROGgeneV2 were used to mine the expression and prognosis of three crucial mRNAs and six verified lncRNAs. Competing endogenous RNA networks were constructed by predicting microRNA response elements and calculating free energy. Results: We found 1658 differentially expressed lncRNAs (778 up-regulated and 880 down-regulated) and 1783 aberrantly expressed mRNAs (909 up-regulated and 874 down-regulated). GO and pathway enrichment analyses revealed the vital functions of the differentially expressed mRNAs, including cell proliferation, cell migration, angiogenesis, and cellular response to zinc ion. The canonical signaling pathways mainly included the interleukin-17, cell cycle, Wnt, and mineral absorption signaling pathways. Six lncRNAs including AC017002.2 (P = 0.039), cancer susceptibility 19 (CASC19) (P = 0.021), LINC00152 (P = 0.013), NONHSAT058834 (P = 0.007), NONHSAT007692 (P = 0.045), and ENST00000415991.1 (P = 0.045) showed significant differences in expression levels between the cancer tissue and paracancer tissue groups. AC017002.2, NONHSAT058834, NONHSAT007692, and ENST00000415991.1 have not yet been reported in RC. The crucial mRNAs myelocytomatosis viral oncogene (MYC), transforming growth factor beta induced (TGFBI), and solute carrier family 7 member 5 (SLC7A5) were selected. AC017002.2 and LINC00152 were positively correlated with MYC, TGFBI, and cytochrome P450 family 2 sub-family B member 6 (All r > 0.900, P < 0.050). NONHSAT058834 was positively associated with MYC (r = 0.930, P < 0.001), and CASC19 was positively correlated with SLC7A5 (r = 0.922, P < 0.001). Conclusion: This study offers convincing evidence of differentially expressed lncRNAs and mRNAs as potential biomarkers in RC.

Construction of a Cerna Network Reveals Potential Lncrna Biomarkers in Rectal Adenocarcinoma

Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.

Constructing the Cerna Regulatory Network and Combining Immune Cells to Evaluate Prognosis of Colon Cancer Patients

Construction of a Novel MYC-Associated ceRNA Regulatory Network to Identify Prognostic Biomarkers in Colon Adenocarcinoma

The Construction and Analysis of Cerna Networks in Invasive Breast Cancer: a Study Based on the Cancer Genome Atlas.

A Competing Endogenous RNA Network Reveals Novel Potential Lncrna, Mirna, and Mrna Biomarkers in the Prognosis of Human Colon Adenocarcinoma.

Biomarker Discovery for the Carcinogenic Heterogeneity Between Colon and Rectal Cancers Based on Lncrna-Associated Cerna Network Analysis.

Construction and Analysis of a Cerna Network Reveals Potential Prognostic Markers in Colorectal Cancer

A Comprehensive Study of Construction and Analysis of Competitive Endogenous RNA Networks in Lung Adenocarcinoma.

Integrated Analysis of Long Non-Coding RNA-associated Cerna Network Reveals Potential Lncrna Biomarkers in Human Lung Adenocarcinoma

Construction and Investigation of a Lncrna-Associated Cerna Regulatory Network in Cholangiocarcinoma.

Identification of Cerna Network Based on a RNA-seq Shows Prognostic Lncrna Biomarkers in Human Lung Adenocarcinoma

Immune-Related lncRNAs to Construct Novel Signatures and Predict the Prognosis of Rectal Cancer

Comprehensive analysis of long non-coding RNA and mRNA expression profile in rectal cancer

Identification of Diagnostic Exosomal LncRNA-miRNA-mRNA Biomarkers in Colorectal Cancer Based on the Cerna Network.

Identification of Lncrna Biomarkers in Hepatocellular Carcinoma by Comprehensive Analysis of the Lncrna-Mediated Cerna Network

Comprehensive Analysis of Differentially Expressed Profiles of Lncrnas and Construction of Mir-133B Mediated Cerna Network in Colorectal Cancer

Construction and Integrated Analysis of a Lncrna-Associated Competing Endogenous RNA Network Reveal Functional Lncrnas in Pancreatic Cancer

Identification and development of long non-coding RNA-associated regulatory network in colorectal cancer.

Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer

To Construct a Cerna Regulatory Network As Prognostic Biomarkers for Bladder Cancer.